Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection
- 15 November 2014
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (5) , 1513-1519
Abstract
The lymph node ratio (LNR) was proposed as a prognostic indicator in Stage III colorectal cancer (CRC) patients in recent studies. The purpose of this study was to evaluate the prognostic impact of the LNR in Stage IV CRC patients who have undergone curative resection. A retrospective review of 119 Stage IV CRC patients who underwent curative resection in our institute from 1997 to 2009 was performed. Patients were divided into two groups (low LNR and high LNR) by means of their median LNR. A disease-free survival (DFS) and an overall survival (OS) were analyzed using the Kaplan–Meier curve; multivariate analysis was performed using the Cox proportional hazard model. The cutoff value for the LNR was 0.111. For the entire study group, the 5-year DFS was 22 % and the 5-year OS was 65 %. DFS was not significantly different between patients in the low LNR group and the high LNR group (25 and 19 %, respectively; P = 0.317), but OS was significantly higher in the low LNR group patients compared with the high LNR group patients (77 and 54 %, respectively; P < 0.001). Using multivariate analysis, we identified the LNR as an independent prognostic factor for OS, with a hazard ratio of 3.08 (95 % CI 1.38–8.19; P = 0.005). LNR is a potent prognostic indicator for stratification in Stage IV CRC patients who have undergone curative resection.Keywords
This publication has 24 references indexed in Scilit:
- Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the LiteratureAnnals of Surgical Oncology, 2011
- Lymph Node Ratio as a Quality and Prognostic Indicator in Stage III Colon CancerAnnals of Surgery, 2011
- Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancerJournal of Surgical Oncology, 2010
- Prognostic Value of the Lymph Node Ratio in Stage III Colorectal Cancer: A Systematic ReviewAnnals of Surgical Oncology, 2010
- A study of lymph node ratio in stage IV colorectal cancerWorld Journal of Surgical Oncology, 2008
- Prognosis of Patients With Colorectal Cancer Is Associated With Lymph Node RatioAnnals of Surgery, 2008
- Adjuvant Chemotherapy After Potentially Curative Resection of Metastases From Colorectal Cancer: A Pooled Analysis of Two Randomized TrialsJournal of Clinical Oncology, 2008
- Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialThe Lancet, 2008
- Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon CarcinomaAnnals of Surgical Oncology, 2007
- Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 TrialJournal of Clinical Oncology, 2006